US Patent 10155727 Pyrazoles

Is a

Patent

Patent attributes

Patent Applicant

Janssen Pharmaceuticals

Current Assignee

Janssen Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

101557270

Patent Inventor Names

Simon Ward0

Ute Egerland0

Barbara Langen0

Rita Dost0

Rudolf Schindler0

Thorsten Hage0

Christian Grunwald0

Hans-Joachim Lankau0

...

Date of Patent

December 18, 2018

Patent Application Number

155038750

Date Filed

August 14, 2015

Patent Citations Received

‌

US Patent 11447503 Pyridine carbamates and their use as GLUN2B receptor modulators

‌

US Patent 10323021 Triazoles as NR2B receptor inhibitors

‌

US Patent 10377753 Substituted 4-azaindoles and their use as GluN2B receptor modulators

‌

US Patent 11530210 Substituted heteroaromatic pyrazolo-pyridines and their use as GLUN2B receptor modulators

‌

US Patent 10617676 Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GluN2B receptor modulators

‌

US Patent 10766880 Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators

‌

US Patent 11008302 Substituted pyridine and pyrimidines and their use as GluN2B receptor modulators

‌

US Patent 11618750 Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulators

...

Patent Primary Examiner

‌

Kamal A Saeed

Patent abstract

The invention relates to pyrazole derivatives which are NMDA NR2B receptor inhibitors, useful in treating central nervous system diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 10155727 Pyrazoles

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 10155727 Pyrazoles